Skip to main content
Clinical Trials/ACTRN12621000512820
ACTRN12621000512820
Recruiting
未知

SUpporting Mothers Milk Intervention Trial comparing different doses of domperidone for treating lactation insufficiency in mothers of preterm infants: A Follow-Up study (Post-SUMMIT)

South Australian Health and Medical Research Institute (SAHMRI)0 sites110 target enrollmentMay 3, 2021

Overview

Phase
未知
Intervention
Not specified
Conditions
actation insufficiency
Sponsor
South Australian Health and Medical Research Institute (SAHMRI)
Enrollment
110
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 3, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
South Australian Health and Medical Research Institute (SAHMRI)

Eligibility Criteria

Inclusion Criteria

  • All women who participated in the SUMMIT trial will be invited to participate. Selection criteria for SUMMIT include:
  • \-Mothers of preterm infants born \<34 weeks' gestation (up to 33\+6\)
  • \-Lactation insufficiency defined as breast milk volume less than 300 mL/day in previous 24 hours if between 7 and 13 days postpartum, or breast milk volume less than 500 mL/day in previous 24 hours if between 14 and 28 days postpartum
  • \-Between 7 and 28 days postpartum
  • \-Expressing with an electric pump an average of 6 times a day or more in previous 24\-48 hours
  • \-Willing and able to comply with all study requirements, including treatment, timing and/or nature of required assessment and follow\-up of mother and baby until infant discharge.
  • \-Signed and written consent.

Exclusion Criteria

  • \- Did not participate in SUMMIT RCT

Outcomes

Primary Outcomes

Not specified

Similar Trials